Document is current
Any future updates will be listed below
-
Authors
Melchers, Max
de Smet, Vivienne
Rooijakkers, Chrissie
Huising, Jonathan
Vermeulen, Wander
Köktaş, Beyza Nur Nisa
van de Vusse, Karlijn Johanna
Sabzewar, Kimia Milani
Mishra, Shakti Bedanta
Bethlehem, Carina
Boer, Dirk P.
Cimic, Nedim
van Duijnhoven, Mirella
Frenzel, Tim
Liesveld, Jordi
Paternoster, Gianluca
Stads, Susanne
Weenink, Jan J.
Festen-Spanjer, Barbara
Pickkers, Peter
van Zanten, Arthur Raymond Hubert https://orcid.org/0000-0001-6276-7192
-
Funding
Funding for this research was provided by:
AOP Health
- License Information
-
More Information
Article History
Received: 18 November 2024
Accepted: 1 April 2025
First Online: 29 April 2025
Declarations
:
: The study received a waiver from the Dutch 'Medical Research Involving Human Subjects Act' from the medical ethical committee of Wageningen University and Research on December 20, 2020. Informed consent was obtained from each subject or, when applicable, from a legal representative, next of kin, or proxy in accordance to local protocols.
: Not applicable.
: MM reported receiving honoraria and travel expenses from AOP pharma. AvZ reported receiving honoraria for advisory board meetings, lectures, research, and travel expenses from AOP Pharma, Abbott, Baxter, Cardinal Health, Danone-Nutricia, DIM3, Dutch Medical Food, Fresenius Kabi, GE Healthcare, InBody, Mermaid, Rousselot, and Lyric. The other authors have nothing to declare.
